DOI: https://doi.org/10.22141/2224-1507.9.2.2019.172121

Giant cell arteritis: epidemiology, diagnosis, prognosis

V.Z. Netiazhenko, O.G. Puzanova

Abstract


Giant cell arteritis (GCA) is the most common systemic vasculitis affecting large vessels in subjects over 50 years old. This di­sease is associated with an increased risk of other inflammatory disea­ses and vascular conditions. Many studies and guidelines focus on sol­ving GCA-associated problems. The aim of this paper is to perform an analytical review, systematic generalization and discussion of evidence on various epidemiological GCA aspects, modern approaches and me­thods of its diagnosis as well as risk factors of unfavorable prognosis.

Keywords


giant cell arteritis; large vessel vasculitis; epidemiology; diagnosis; prognosis

References


Jenette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.

Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessels vasculitis in clinical practice. Ann Rheum Dis. 2018 May;77(5):636-643. doi: 10.1136/annrheumdis-2017-212649.

Baslund B, Helleberg M, Faurschou M, Obel N. Mortality in patients with giant cell arteritis. Rheuma-tology (Oxford). 2015 Jan;54(1):139-143. doi: 10.1093/rheumatology/keu303.

de Boysson H, Liozon E, Lariviere D, et al. Giant cell arteritis-related stroke: a retrospective multicenter case-control study. J Rheum. 2017;44(3):297-303. doi: 10.3899/jrheum.161033.

Crow RW, Katz BJ, Warner JE, et al. Giant Cell Arteritis and Mortality. J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):365-369. doi:10.1093/gerona/gln030.

González-Gay MA, Pina T. Giant Cell Arteritis and Polymyalgia Rheumatica: an Update. Curr Rheu-matol Rep. 2015 Feb;17(2):6. doi: 10.1007/s11926-014-0480-1.

Sigl M, Hsu E, Scheffel H, Haneder S, Rümenapf G, Amendt K. Lower extremity vasculitis in giant cell arteritis: important differential diagnosis in patient with lower limb claudication. Vasa. 2014 Sep;43(5):326-336. doi: 10.1024/0301-1526/a000370.

Udayakumar PD, Crowson CS, Warrington KJ, Matteson EL. Incidence of giant cell arteritis in the cur-rent era of advanced diagnostic imaging. Ann Rheum Dis. 2013;72(Suppl 3):FRI0353. doi: 10.1136/annrheumdis-2013-eular.1480.

Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of giant cell arte-ritis. Rheumatology (Oxford). 2010;49:1594-1597. doi: 10.1093/rheumatology/keq039a.

Bienvenu B, Ly KH, Lambert M, et al. Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). Rev Med Intern. 2016;37(3):154-165. doi: 10.1016/j.revmed.2015.12.015.

Beketova TV, Satybaldyev AM, Denisov LN. International guidelines for the management of giant cell arteritis and polymyalgia rheumatica: The 2015 results. Nauchno-prakticheskaya revmatologiya. 2016;54(4):390-394. doi: 10.14412/1995-4484-2016-390-394.

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA. 2016 Jun;315(22):2442-2458. doi: 10.1001/jama.2016.5444.

Guevara M, Kollipara CS. Recent Advances in Giant Cell Arteritis. Curr Rheumatol Rep. 2018 Apr 2;20(5):25. doi: 10.1007/s11926-018-0737-1.

Kermani TA, Schäfer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010 Apr;69(4):780-781. doi: 10.1136/ard.2009.111005.

Koster MJ, Matteson EL, Warrington KJ. Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology. 2018;57:ii32-ii42. doi: 10.1093/rheumatology.kex424.

Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol. 2002 Jan;14(1):3-10.

Nesher G, Breuer SG. Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update. Rambam Mai-monides Med. 2016;7(4):e0035. doi: 10.5041/RMMJ.10262.

Ness T, Bley TA, Schmidt WA, Lamprecht P. The Diagnosis and Treatment of Giant Cell Arteritis. Dtsch Arztebl Int. 2013 May;110(21):376-386. doi: 10.3238/arztebl.2013.0376.

Watanabe R, Hilhorst M, Zhang H, et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions. JCI Insight. 2018 Oct 18;3(20). pii: 123047. doi: 10.1172/jci.insight.123047.

Laviriere D, Sacre K, Klein I, et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study. Medicine (Baltimore). 2014 Dec;93(28):e265. doi: 10.1097/MD.0000000000000265.

Chen JJ, Leavitt JA, Fang C, et al. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis. Ophthalmology. 2016 Sep;123(9):1999-2003. doi: 10.1016/j.ophtha.2016.05.008.

Machado EB, Michet CJ, Ballard DJ, et al. Trends in incidence and clinical presentations of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988 Jun;31(6):745-749.

Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Mortality of large-artery complications (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with gi-ant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003 Dec;48(12):3532-7. doi: 10.1002/art.11480.

Machado EB, Gabriel SE, Beard CM, Michet CJ, O’Fallon WM, Ballard DJ. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenera-tive vascular disease? Int J Epidemiol. 1989 Dec;18(4):836-841. doi: 10.1093/ije/18.4.836.

Crowson CS, Matteson EL, Myasoedova E, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar;63(3):633-639. doi: 10.1002/art.30155.

Stellingwerff MD, Brouwer E, Lensen KJ, et al. Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization. Medicine (Baltimore). 2015 Sep;94(37):e1542. doi: 10.1097/MD.0000000000001542.

Genda E, Oyoo O, Adebajo A. Vasculitis in Africa. Curr Rheumatol Rep. 2018 Feb 21;20(2):4. doi: 10.1007/s11926-018-0711-y.

Watts RA, Scott DG. Epidemiology of vasculitis. In: Ball GV, Fessler BJ, Bridges SL, eds. Oxford text-book of vasculitis. 3rd ed. Oxford: Oxford University Press; 2014. 7-28 pp. doi: 10.1093/med/9780199659869.003.0002.

Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and Predic-tors of Large-Artery Complication (Aortic Aneurysm, Aortic Dissection, and/or Large-Artery Stenosis) in Patients with Giant Cell Arteritis: A Population-Based Study Over 50 Years. Arthritis Rheum. 2003 Dec;48(12):3522-31. doi: doi.org/10.1002/art.11353.

Hellmich B. Management der Polymyalgia rheumatica und der Großgefäßvaskulitiden. Internist (Berl). 2016 Nov;57(11):1069-1078. doi: 10.1007/s00108-016-0131-x.

Petri H, Nevitt A, Saesour K, Napalkov P, Collinson N. Incidence of giant cell arteritis and characteris-tics of patients: data-driven analysis of comorbidities. Arthritis Care Res (Hoboken). 2015 Mar;67(3):390-395. doi: 10.1002/acr.22429.

Lensen KD, Voskuyl AE, van der Laken CS, et al. 18F-fluorodeoxyglucose positron emission tomogra-phy in elderly patients with elevated erythrocyte sedimentation rate of unknown origin. PloS One. 2013;8(3):e58917. doi: 10.1371./journal.pone.0058917.

Hill CL, Black RJ, Nossent JC, et al. Risk of mortality in patients with giant cell arteritis. Semin Arthritis Rheum. 2017;46(4):513-519. doi: 10.1016/j.semarthrit.2016.08.015.

Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995 Apr 1;122(7):502-7.

Mackie SL, Hensor EM, Morgan AW, Pease CT. Should I send my patient with previous giant cell arte-ritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann Rheum Dis. 2014;73(1):143-148. doi: 10.1136/annrheumdis-2012-202145.

Robson JC, Kiran A, Maskell J, et al. The relative risk of aortic aneurysm in patient with giant cell arte-ritis compared with the general population of the UK. Ann Rheum Dis. 2015;74(1):129-135. doi: 10.1136/annrheumdis-2013-204113.

Kermani TA, Warrington KJ, Crowson CS, et al. Large Vessel Involvement in Giant Cell Arteritis: A Population-Based Cohort Study of the Incidence-Trends and Prognosis. Ann Rheum Dis. 2013;72(12):1989-1994. doi: 10.1136/annrheumdis-2012-202408.

Matteson EL, Buttgereit F, Dejaco C, Dasgupta B. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis. Rheum Dis Clin North Am. 2016 Feb;42(1):75-90, viii. doi: 10.1016/j.rdc.2015.08.009.

Laviriere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography for the diagnosis of giant cell arteritis. A real-life prospective study. Medicine (Baltimore). 2016 Jul;95(30):e4146. doi: 10.1097/MD.0000000000004146.

Alsolaimani RS, Bhavsar SV, Khalidi NA, et al. Severe intracranial involvement in giant cell arteritis: 5 cases and literature review. J Rheumatol. 2016 Mar;43(3):648-656. doi: 10.3899/jrheum.150143.

Ungprasert P, Wijampreecha K, Koster MJ, Thongprayoon C, Warrington KJ. Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies. Semin Ar-thritis Rheum. 2016 Dec;46(3):361-366. doi: 10.1016/j.semarthrit.2016.07.005.

Ungprasert P, Koster MJ, Warrington KJ. Coronary artery disease in giant cell arteritis: a systematic re-view and meta-analysis. Semin Arthritis Rheum. 2015;44(5):586-591. doi: 10.1016/j.semarthrit.2014.10.010.

Ungprasert P, Thongprayoon C, Kittonamingkolchai W, Srivali N, Cheungpasitporn W. Peripheral arte-rial disease in patients with giant cell arteritis: a meta-analysis. Int J Rheum Dis. 2016 Aug;19(8):819-825. doi: 10.1111/1756-185X.12631.

Ungprasert P, Sanguankeo A, Upala S, Knight EL. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014 Dec;44(3):366-370. doi: 10.1016/j.semarthrit.2014.06.004.

Ungprasert P, Upala S, Sanguankeo A, Warrington KJ. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: a systematic review and meta-analysis. Mod Rheumatol. 2016;26(3):410-414. doi: 10.3109/14397595.2015.1081722.

Li L, Neogi T, Jick S. Giant cell arteritis and vascular diseases − risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford). 2017 May;56(5):753-762. doi: 10.1093/rheumatology/kew482.

Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for classification of giant cell arteritis. Arthritis Rheum. 1990 Aug;33(8):1122-1128. doi: 10.1002/art.1780330810.

Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histological documentation. Semin Arthritis Rheum. 1995;24(6):422-431.

Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999 Feb;42(2):311-317. doi: https://doi.org/10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F

Muratore F, Kermani TA, Crowson CS, et al. Large-vessel giant cell arteritis: a cohort study. Rheuma-tology (Oxford). 2015;54(3):463-470. doi: 10/1093/rheumatology/keu329.

Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287(1):92-101. doi: 10.1001/jama.287.1.92.

Ghinoi A, Pipitone N, Nicolini A, et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford). 2012 Apr;51(4):730-734. doi: 10.1093/rheumatology/ker329.

Bongartz T, Matteson EL. Large vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18(1):10-17.

Maksimovicz-McKinnon K, Clark TM, Hoffmann GS. Takayasu arteritis and giant cell arteritis: a spec-trum within the same disease? Medicine (Baltimore). 2009;88(4):221-226. doi: 10.1097/MD.0b013e3181af70c1.

Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremi-ty arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47(1):96-101. doi: 10.1093/rheumatology/kem322.

Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371(1):50-57. doi: 10.1056/NEJMcp1214825.

Cavazza A, Muratore F, Boiardi L, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol. 2014 Oct;38(10):1360-1370. doi: 10.1097/PAS.0000000000000244.

Kermani TA, Matteson EL, Hunder GG, Warrington KJ. Symptomatic Lower Extremity Vasculitis in Giant Cell Arteritis: a Case Series. J Rheumatol. 2009 Oct;36(10):2277-2283. doi: 10.3899/rheum.090269.

Alba MA, Garcia-Martinez A, Prieto-Gonzáles S, et al. Relapses in patients with giant cell arteritis: prev-alence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 pa-tients. Medicine (Baltimore). 2014 Jul;93(5):194-201. doi: 10.1097/MD.0000000000000033.

Restuccia G, Boiardi L, Cavazza A, et al. Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study. Medicine (Baltimore). 2016 May;95(19):e3524. doi: 10.1097/MD.0000000000003524.

Restuccia G, Boiardi L, Cavazza A, et al. Long-term remission in biopsy-proven giant cell arteritis: a ret-rospective cohort study. J Autoimmun. 2017 Feb;77:39-44. doi: 10.1016/j.jaut.2016.10.002.

Martinez-Lado L, Calviño-Diaz C, Piñeiro A, et al. Relapses and recurrenceses in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine (Baltimore). 2011 May;90(3):186-193. doi: 10.1097/MD.0b013e31821c4fad.

Labarca С, Koster MJ, Crowson CS, et al. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford). 2016 Feb;55(2):347-356. doi: 10.1093/rheumatology/kev348.

Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they? Semin Arthritis Rheum. 2015;44(6):724-728. doi: 10.1016/jseminarthrit.2015.01.005.

Schmidt WA. Role of ultrasound in the understanding and management of vasculitis. Ther Adv Muscu-loskelet Dis. 2014;6(2):39-47. doi: 10.1177/1759720X13512256.

Koster MJ, Warrington KJ. Classification of large vessel vasculitis. Can we separate giant cell arteritis from Takayasu arteritis? Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e205-e213. doi: 10.1016/j.lpm.2016.11.032.

Futura S, Cousins C, Chaudhry A. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol. 2015;42(2):300-308. doi: 10.3899/jrheum.140562.

Blockmans D, de Ceuninck DL, Vanderschüren S, Knockärt D, Mortelmans L, Bobbärs H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131-137. doi: 10.1002/art.21699.

Agard C, Barrier JH, Dupas B, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59(5):670-676. doi: 10.1002/art.23577.

Prieto-González S, Arguis P, Garsia-Martinez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71(7):1170-1176. doi: 10.1136/annrheumdis-2011-200865.

Prieto-González S, Depetris M, Garsia-Martinez A, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed biopsy-proven giant cell arteritis: a prospec-tive, case-control study. Ann Rheum Dis. 2014;73(7):1388-1392. doi: 10.1136/annrheumdis-2013-204572.

García-Martínez A, Hernández-Rodríguez J, Arguis P, et al. Development of aortic aneurysm / dilatation during the follow-up of patients with giant cell arteritis: a cross-sectional screening of fifty-four pro-spectively followed patients. Arthritis Rheum. 2008;59(3):422-430. doi: 10.1002/art.23315.

Mekinian A, Djelbani S, Viry F, Fain O, Soussan M. Usefulness of imaging in large vessel vasculitis. Rev Med Interne. 2016;37(4):245-255. doi: 10.1016/j.revmed.2015.10.353.

Lensen KD, Voskuyl AE, Comans EF, van der Laken CJ, Smulders YM. Extracranial giant cell arteritis: A narrative review. Neth J Med. 2016;74(5):182-192.

Schmidt J, Duhaut P. Aortitis in giant cell arteritis. Rev Med Interne. 2016;37(4):239-244. doi: 10.1016/j.revmed.2015.12.018.

Lee YH, Choi SJ, Ji JD, Song GG. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis. Z Rheumatol. 2016;75(9):924-931. doi: 10.1007/s00393-015-1674-2.

Besson FL, Parienti JJ, Bienvenu B. Diagnostic perfomance of 18F-fluorodeoxyglucose positron emis-sion tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med. 2011;38(9):1764-1772. doi: 10.1007/s00259-011-1830-0.

Soussan M, Nicolas P, Schramm C, et al. Management of large-vessel vasculitis with FDG-PET: a sys-tematic literature review and meta-analysis. Medicine (Baltimore). 2015;94:e622. doi: 10.1097/MD.0000000000000622.

Schmidt, WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47(9):1406-1408. doi: 10.1093/rheumatology/ken258.

Diamantopulos AP, Haugeberg G, Hetland H, Soldal DM, Bie R, Myklebust G. Diagnostic value of col-our Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res (Hoboken). 2014;66(1):113-119. doi: 10.1002/acr.22178.

Prieto-González S, Terrades-Garsia N, Corbera-Bellalta M, et al. Serum osteopontin: a biomarker of dis-ease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical use-fulness in tocilizumab-treated patients. RMD Open. 2017 Dec;3(2):e000570. doi: 10.1136/rdmopen-2017-000570.

Prieto-González S, Garsia-Martinez A, Tavera-Bahillo I, et al. Effect of glucocorticoid treatment on computer tomography angiography detected large vessel inflammation in giant cell arteritis. A prospec-tive, longitudinal study. Medicine (Baltimore). 2015 Feb;94(5): e486. doi: 10.1097/MD.0000000000000486.






Copyright (c) 2019 PAIN. JOINTS. SPINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта